Abiopharma

Holdings of interested parties/officers as of 30.6.26

Register of shareholders, changes and share capital status - exercise and expiration of warrants (unlisted) for employees according to outline

Change in holdings of interested parties/officers

Holdings of interested parties/officers as of 25.6.26

Register of shareholders, changes and capital status – partial redemption of BONDS (Series 7 and Series 8)

Management and officers – staffing as of 18.6.26

Appointment of director - Rami Hazzan, starting from 18.6.26

Ceased to serve as a director - Gideon Kadusi as of 18.6.26

Results of the general meeting dated 18.6.26

Register of shareholders, changes and capital status – exercise of warrants for shares (unlisted) by employees